TRDA
Entrada Therapeutics, Inc.
$12.22
Earnings Summary
Revenue | $41.85Mn |
Net Profits | $-9.54Mn |
Net Profit Margins | -22.81% |
Highlights
Entrada Therapeutics, Inc.’s revenue jumped +Inf% since last year same period to $41.85Mn in the Q4 2023. On a quarterly growth basis, Entrada Therapeutics, Inc. has generated -4.31% fall in its revenue since last 3-months.
Entrada Therapeutics, Inc.’s net profit jumped 57.02% since last year same period to $-9.54Mn in the Q4 2023. On a quarterly growth basis, Entrada Therapeutics, Inc. has generated -126.91% fall in its net profits since last 3-months.
Entrada Therapeutics, Inc.’s net profit margin jumped NaN% since last year same period to -22.81% in the Q4 2023. On a quarterly growth basis, Entrada Therapeutics, Inc. has generated -128.13% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Entrada Therapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.59 |
EPS Estimate Current Year | -0.59 |
Highlights
Entrada Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.59 - a -247.06% fall from last quarter’s estimates.
Entrada Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.59.
Key Ratios
Key ratios of the Entrada Therapeutics, Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -0.29 |
Highlights
Entrada Therapeutics, Inc.’s earning per share (EPS) jumped 63.29% since last year same period to -0.29 in the Q4 2023. This indicates that the Entrada Therapeutics, Inc. has generated 63.29% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-03-13 | -0.17 | -0.29 | -70.59% |
2023-11-07 | -0.74 | 1.02 | 237.84% |
2023-05-10 | 0.97 | -0.21 | -121.65% |
2023-08-08 | -0.69 | -0.78 | -13.04% |
₹0 US Stocks a/c Opening Fee